![Andreas Norlin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andreas Norlin
Directeur Technique/Scientifique/R&D chez
ASCELIA PHARMA AB
Profil
Andreas L.
Norlin is the founder of Xkout Bioscience AB. Dr. Norlin currently holds the positions of Director at ApoGlyx AB, Director at Desupervised ApS, and Chief Scientific Officer at Ascelia Pharma AB since 2020.
Dr. Norlin completed graduate and doctorate degrees at the University of Lund.
Postes actifs de Andreas Norlin
| Sociétés | Poste | Début |
|---|---|---|
| ASCELIA PHARMA AB | Directeur Technique/Scientifique/R&D | 01/01/2020 |
ApoGlyx AB
 ApoGlyx AB BiotechnologyHealth Technology Engages in research and development in biochemistry | Directeur/Membre du Conseil | - |
Anciens postes connus de Andreas Norlin
| Sociétés | Poste | Fin |
|---|---|---|
Xkout Bioscience AB | Fondateur | - |
Formation de Andreas Norlin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
19
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ApoGlyx AB
ApoGlyx AB BiotechnologyHealth Technology Engages in research and development in biochemistry | Health Technology |
Ascelia Pharma AB
 Ascelia Pharma AB Pharmaceuticals: MajorHealth Technology Operates as oncology-dedicated drug development company, which develops novel drugs to improve life expectancy | Health Technology |
Xkout Bioscience AB |
